{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:22:38Z","timestamp":1794298958267,"version":"4.9.0"},"reference-count":55,"publisher":"Journal of Biomedical Research","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2026]]},"DOI":"10.7555\/jbr.39.20250238","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:59:37Z","timestamp":1775635177000},"page":"1","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic-based cellular pharmacokinetics analysis reveals hypoxia-driven chemotherapy sensitivity in Mongolian gastric cancer"],"prefix":"10.7555","volume":"40","author":[{"given":"Jiawen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.1","doi-asserted-by":"publisher","unstructured":"O'Donnell PH, Dolan ME. Cancer pharmacoethnicity: Ethnic differences in susceptibility to the effects of chemotherapy[J]. <i>Clin Cancer Res<\/i>, 2009, 15(15): 4806\u20134814.","DOI":"10.1158\/1078-0432.CCR-09-0344"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.2","doi-asserted-by":"publisher","unstructured":"Pathak S, Zajac KK, Annaji M, et al. Clinical outcomes of chemotherapy in cancer patients with different ethnicities[J]. <i>Cancer Rep<\/i>, 2023, 6(9): e1830.","DOI":"10.1056\/NEJMoa1504627"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.3","doi-asserted-by":"publisher","unstructured":"Bianchi DW, Brennan PF, Chiang MF, et al. The All of Us Research Program is an opportunity to enhance the diversity of US biomedical research[J]. <i>Nat Med<\/i>, 2024, 30(2): 330\u2013333.","DOI":"10.1038\/s41591-023-02744-3"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.4","doi-asserted-by":"publisher","unstructured":"The All of Us Research Program Genomics Investigators. Genomic data in the All of Us Research Program[J]. <i>Nature<\/i>, 2024, 627(8003): 340\u2013346.","DOI":"10.1038\/s41586-023-06957-x"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.5","doi-asserted-by":"publisher","unstructured":"Bai H, Guo X, Narisu N, et al. Whole-genome sequencing of 175 Mongolians uncovers population-specific genetic architecture and gene flow throughout North and East Asia[J]. <i>Nat Genet<\/i>, 2018, 50(12): 1696\u20131704.","DOI":"10.1038\/s41588-018-0250-5"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.6","doi-asserted-by":"publisher","unstructured":"Wang F, Zhang X, Tang L, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023[J]. <i>Cancer Commun (Lond)<\/i>, 2024, 44(1): 127\u2013172.","DOI":"10.1002\/cac2.12516"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.7","doi-asserted-by":"publisher","unstructured":"Ajani JA, D'Amico TA, Bentrem DJ, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology[J]. <i>J Natl Compr Canc Netw<\/i>, 2022, 20(2): 167\u2013192.","DOI":"10.6004\/jnccn.2022.0008"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.8","doi-asserted-by":"publisher","unstructured":"Gantuya B, Oyuntsetseg K, Bolor D, et al. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area[J]. <i>Gastric Cancer<\/i>, 2019, 22(1): 104\u2013112.","DOI":"10.1007\/s10120-018-0844-8"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.9","doi-asserted-by":"publisher","unstructured":"Jin G, Lv J, Yang M, et al. Genetic risk, incident gastric cancer, and healthy lifestyle: A meta-analysis of genome-wide association studies and prospective cohort study[J]. <i>Lancet Oncol<\/i>, 2020, 21(10): 1378\u20131386.","DOI":"10.1016\/S1470-2045(20)30460-5"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.10","doi-asserted-by":"publisher","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the   <inline-formula>   <tex-math id=\"M1-1\">\\begin{document}$ 2^{-\\Delta \\Delta C_{{\\mathrm{T}}}} $\\end{document}<\/tex-math>  <\/inline-formula> method[J]. <i>Methods<\/i>, 2001, 25(4): 402\u2013408.","DOI":"10.1006\/meth.2001.1262"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.11","doi-asserted-by":"publisher","unstructured":"Ringn\u00e9r M. What is principal component analysis?[J]. <i>Nat Biotechnol<\/i>, 2008, 26(3): 303\u2013304.","DOI":"10.1038\/nbt0308-303"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.12","doi-asserted-by":"publisher","unstructured":"Ito K, Murphy D. Application of <i>ggplot2<\/i> to pharmacometric graphics[J]. <i>CPT Pharmacometrics Syst Pharmacol<\/i>, 2013, 2(10): e79.","DOI":"10.1038\/psp.2013.56"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.13","doi-asserted-by":"publisher","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. <i>Genome Biol<\/i>, 2014, 15(12): 550.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.14","doi-asserted-by":"publisher","unstructured":"Ashburner M, Ball CA, Blake JA, et al. Gene ontology: Tool for the unification of biology[J]. <i>Nat Genet<\/i>, 2000, 25(1): 25\u201329.","DOI":"10.1038\/75556"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.15","doi-asserted-by":"publisher","unstructured":"Yu G, Wang L, Han Y, et al. clusterProfiler: An R package for comparing biological themes among gene clusters[J]. <i>Omics<\/i>, 2012, 16(5): 284\u2013287.","DOI":"10.1089\/omi.2011.0118"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.16","doi-asserted-by":"publisher","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes[J]. <i>Nucleic Acids Res<\/i>, 2000, 28(1): 27\u201330.","DOI":"10.1093\/nar\/28.1.27"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.17","doi-asserted-by":"publisher","unstructured":"Schubert M, Klinger B, Kl\u00fcnemann M, et al. Perturbation-response genes reveal signaling footprints in cancer gene expression[J]. <i>Nat Commun<\/i>, 2018, 9(1): 20.","DOI":"10.1038\/s41467-017-02391-6"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.18","doi-asserted-by":"publisher","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles[J]. <i>Proc Natl Acad Sci U S A<\/i>, 2005, 102(43): 15545\u201315550.","DOI":"10.1073\/pnas.0506580102"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.19","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: An R package for predicting <i>in vivo<\/i> or cancer patient drug response and biomarkers from cell line screening data[J]. <i>Brief Bioinform<\/i>, 2021, 22(6): bbab260.","DOI":"10.1093\/bib\/bbab260"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.20","doi-asserted-by":"publisher","unstructured":"Song Q, Yu H, Cheng Y, et al. Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment[J]. <i>J Transl Med<\/i>, 2022, 20(1): 308.","DOI":"10.1186\/s12967-022-03508-2"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.21","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-S\u00e1nchez LM, Jurado-G\u00e1mez B, Feu-Collado N, et al. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics[J]. <i>Am J Physiol Lung Cell Mol Physiol<\/i>, 2017, 313(4): L664\u2013L676.","DOI":"10.1152\/ajplung.00119.2017"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.22","doi-asserted-by":"publisher","unstructured":"Janjigian YY, Kawazoe A, Ya\u00f1ez P, et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer[J]. <i>Nature<\/i>, 2021, 600(7890): 727\u2013730.","DOI":"10.1038\/s41586-021-04161-3"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.23","doi-asserted-by":"publisher","unstructured":"Katoh Y, Katoh M. Comparative integromics on FAT1, FAT2, FAT3 and FAT4[J]. <i>Int J Mol Med<\/i>, 2006, 18(3): 523\u2013528.","DOI":"10.3892\/ijmm.18.3.523"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.24","doi-asserted-by":"publisher","unstructured":"Waldum HL, Hauso \u00d8, Fossmark R. The regulation of gastric acid secretion\u2013clinical perspectives[J]. <i>Acta Physiol (Oxf)<\/i>, 2014, 210(2): 239\u2013256.","DOI":"10.1111\/apha.12208"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.25","doi-asserted-by":"publisher","unstructured":"Li S, Cong X, Gao H, et al. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells[J]. <i>J Exp Clin Cancer Res<\/i>, 2019, 38(1): 6.","DOI":"10.1186\/s13046-018-1003-0"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.26","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, et al. The Cancer Genome Atlas Pan-Cancer analysis project[J]. <i>Nat Genet<\/i>, 2013, 45(10): 1113\u20131120.","DOI":"10.1038\/ng.2764"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.27","doi-asserted-by":"publisher","unstructured":"Chen S, Fang X, Wang Q, et al. PHD\/HIF-1 upregulates CA12 to protect against degenerative disc disease: A human sample, <i>in vitro<\/i> and <i>ex vivo<\/i> study[J]. <i>Lab Invest<\/i>, 2016, 96(5): 561\u2013569.","DOI":"10.1038\/labinvest.2016.32"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.28","doi-asserted-by":"publisher","unstructured":"Waheed A, Sly WS. Carbonic anhydrase \u216b functions in health and disease[J]. <i>Gene<\/i>, 2017, 623: 33\u201340.","DOI":"10.1016\/j.gene.2017.04.027"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.29","doi-asserted-by":"publisher","unstructured":"Jing X, Yang F, Shao C, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment[J]. <i>Mol Cancer<\/i>, 2019, 18(1): 157.","DOI":"10.1186\/s12943-019-1089-9"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.30","doi-asserted-by":"publisher","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation[J]. <i>Annu Rev Cell Dev Biol<\/i>, 2011, 27: 441\u2013464.","DOI":"10.1146\/annurev-cellbio-092910-154237"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.31","doi-asserted-by":"publisher","unstructured":"Zhao R, Jiang S, Zhang L, et al. Mitochondrial electron transport chain, ROS generation and uncoupling (Review)[J]. <i>Int J Mol Med<\/i>, 2019, 44(1): 3\u201315.","DOI":"10.3892\/ijmm.2019.4188"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.32","doi-asserted-by":"publisher","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation[J]. <i>Science<\/i>, 2009, 324(5930): 1029\u20131033.","DOI":"10.1126\/science.1160809"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.33","doi-asserted-by":"publisher","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest[J]. <i>Nucleic Acids Res<\/i>, 2023, 51(D1): D638\u2013D646.","DOI":"10.1093\/nar\/gkac1000"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.34","doi-asserted-by":"publisher","unstructured":"Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: Results from a meta-analysis of cohort studies[J]. <i>Eur J Cancer<\/i>, 2009, 45(16): 2867\u20132873.","DOI":"10.1016\/j.ejca.2009.04.019"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.35","doi-asserted-by":"publisher","unstructured":"Zhang R, Li H, Li N, et al. Risk factors for gastric cancer: A large-scale, population-based case-control study[J]. <i>Chin Med J (Engl)<\/i>, 2021, 134(16): 1952\u20131958.","DOI":"10.1097\/CM9.0000000000001652"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.36","doi-asserted-by":"publisher","unstructured":"Rota M, Pelucchi C, Bertuccio P, et al. Alcohol consumption and gastric cancer risk\u2014A pooled analysis within the StoP project consortium[J]. <i>Int J Cancer<\/i>, 2017, 141(9): 1950\u20131962.","DOI":"10.1016\/j.cbi.2021.109365"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.37","doi-asserted-by":"publisher","unstructured":"Wang C, Liao Y, He W, et al. Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib <i>via<\/i> binding to EGFR in hepatocellular carcinoma[J]. <i>J Exp Clin Cancer Res<\/i>, 2021, 40(1): 113.","DOI":"10.1186\/s13046-021-01904-y"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.38","doi-asserted-by":"publisher","unstructured":"Li L, Zhu Z, Zhao Y, et al. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics[J]. <i>Sci Rep<\/i>, 2019, 9(1): 7827.","DOI":"10.1038\/s41598-019-43924-x"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.39","doi-asserted-by":"publisher","unstructured":"Fan J, de Lannoy IAM. Pharmacokinetics[J]. <i>Biochem Pharmacol<\/i>, 2014, 87(1): 93\u2013120.","DOI":"10.1016\/j.bcp.2013.09.007"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.40","doi-asserted-by":"publisher","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation[J]. <i>Pharmacol Ther<\/i>, 2013, 138(1): 103\u2013141.","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.41","doi-asserted-by":"publisher","unstructured":"van Schaik RH. CYP450 pharmacogenetics for personalizing cancer therapy[J]. <i>Drug Resist Updat<\/i>, 2008, 11(3): 77\u201398.","DOI":"10.1016\/j.drup.2008.03.002"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.42","doi-asserted-by":"publisher","unstructured":"Wishart DS, Knox C, Guo AC, et al. DrugBank: A knowledgebase for drugs, drug actions and drug targets[J]. <i>Nucleic Acids Res<\/i>, 2008, 36(suppl_1): D901\u2013D906.","DOI":"10.1093\/nar\/gkm958"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.43","doi-asserted-by":"publisher","unstructured":"Costello JC, Heiser LM, Georgii E, et al. A community effort to assess and improve drug sensitivity prediction algorithms[J]. <i>Nat Biotechnol<\/i>, 2014, 32(12): 1202\u20131212.","DOI":"10.1038\/nbt.2877"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.44","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. <i>CA Cancer J Clin<\/i>, 2021, 71(3): 209\u2013249.","DOI":"10.3410\/f.739487650.793592245"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.45","doi-asserted-by":"publisher","unstructured":"Wong MCS, Huang J, Chan PSF, et al. Global incidence and mortality of gastric cancer, 1980\u20132018[J]. <i>JAMA Netw Open<\/i>, 2021, 4(7): e2118457.","DOI":"10.1001\/jamanetworkopen.2021.18457"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.46","doi-asserted-by":"publisher","unstructured":"Morgan E, Arnold M, Camargo MC, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: A population-based modelling study[J]. <i>EClinicalMedicine<\/i>, 2022, 47: 101404.","DOI":"10.1016\/j.eclinm.2022.101404"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.47","doi-asserted-by":"publisher","unstructured":"GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: A systematic analysis for the Global Burden of Disease study 2017[J]. <i>Lancet Gastroenterol Hepatol<\/i>, 2020, 5(1): 42\u201354.","DOI":"10.1016\/S2468-1253(19)30328-0"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.48","doi-asserted-by":"publisher","unstructured":"Ginsburg GS, Denny JC, Schully SD. Data-driven science and diversity in the All of Us Research Program[J]. <i>Sci Transl Med<\/i>, 2023, 15(726): eade9214.","DOI":"10.1126\/scitranslmed.ade9214"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.49","doi-asserted-by":"publisher","unstructured":"Turajlic S, Sottoriva A, Graham T, et al. Resolving genetic heterogeneity in cancer[J]. <i>Nat Rev Genet<\/i>, 2019, 20(7): 404\u2013416.","DOI":"10.1038\/s41576-019-0114-6"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.50","doi-asserted-by":"publisher","unstructured":"Li B, Cai Y, Chen C, et al. Genetic variants that impact alternative polyadenylation in cancer represent candidate causal risk loci[J]. <i>Cancer Res<\/i>, 2023, 83(21): 3650\u20133666.","DOI":"10.1158\/0008-5472.CAN-23-0251"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.51","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Jim\u00e9nez F, Mui\u00f1os F, Sent\u00eds I, et al. A compendium of mutational cancer driver genes[J]. <i>Nat Rev Cancer<\/i>, 2020, 20(10): 555\u2013572.","DOI":"10.1038\/s41568-020-0290-x"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.52","doi-asserted-by":"publisher","unstructured":"Xu J, Liao K, Fu Z, et al. Screening differentially expressed genes of pancreatic cancer between Mongolian and Han people using bioinformatics technology[J]. <i>BMC Cancer<\/i>, 2020, 20(1): 298.","DOI":"10.1186\/s12885-020-06722-7"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.53","doi-asserted-by":"publisher","unstructured":"Su XL, Ba B, Cui HW, et al. Cytochrome P450 2E1 RsaI\/PstI and DraI polymorphisms are risk factors for lung cancer in Mongolian and Han population in Inner Mongolia[J]. <i>Chin J Cancer Res<\/i>, 2011, 23(2): 107\u2013112.","DOI":"10.1016\/j.compbiomed.2022.106460"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.54","doi-asserted-by":"publisher","unstructured":"Zhou F, Zhang J, Li P, et al. Toward a new age of cellular pharmacokinetics in drug discovery[J]. <i>Drug Metab Rev<\/i>, 2011, 43(3): 335\u2013345.","DOI":"10.3109\/03602532.2011.560607"},{"key":"10.7555\/JBR.39.20250238.swyxyjzzywb.55","doi-asserted-by":"publisher","unstructured":"Zhang J, Zhou F, Lu M, et al. Pharmacokinetics-pharmacology disconnection of herbal medicines and its potential solutions with cellular pharmacokinetic-pharmacodynamic strategy[J]. <i>Curr Drug Metab<\/i>, 2012, 13(5): 558\u2013576.","DOI":"10.2174\/1389200211209050558"}],"container-title":["Journal of Biomedical Research"],"original-title":[],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:46:09Z","timestamp":1794296769000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.39.20250238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"alternative-id":["JBR-2025-0238"],"URL":"https:\/\/doi.org\/10.7555\/jbr.39.20250238","relation":{},"ISSN":["1674-8301","1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"},{"value":"1674-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}